Everolimus and Letrozole or Hormonal Therapy to Treat Endometrial Cancer

Condition:   Advanced, Persistent, or Recurrent Endometrial CancerInterventions:   Drug: Everolimus;   Drug: Tamoxifen;   Drug: Letrozole;   Drug: Medroxyprogesterone AcetateSponsors:   Gynecologic Oncology Group;   Novartis PharmaceuticalsNot yet recruiting - verified August 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials